Virtu Financial LLC Invests $570,000 in McKesson Co. (NYSE:MCK)

Virtu Financial LLC acquired a new position in shares of McKesson Co. (NYSE:MCK - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 1,000 shares of the company's stock, valued at approximately $570,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Millstone Evans Group LLC acquired a new position in McKesson during the 4th quarter worth approximately $28,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of McKesson during the 3rd quarter worth $31,000. Synergy Asset Management LLC acquired a new position in shares of McKesson during the 4th quarter worth $32,000. Crews Bank & Trust purchased a new position in shares of McKesson in the 4th quarter valued at about $33,000. Finally, Atala Financial Inc acquired a new stake in shares of McKesson in the fourth quarter valued at about $34,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Stock Performance

NYSE MCK traded up $2.58 during trading hours on Friday, hitting $668.25. 566,680 shares of the company's stock were exchanged, compared to its average volume of 837,100. The business's 50 day moving average is $623.58 and its 200-day moving average is $579.34. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $672.00. The firm has a market capitalization of $83.75 billion, a P/E ratio of 30.60, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. As a group, equities research analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

Remove Ads

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.42%. McKesson's dividend payout ratio is presently 13.00%.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the company's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,689 shares of company stock worth $11,187,351. 0.11% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on MCK. Mizuho assumed coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 target price for the company. Morgan Stanley lifted their price objective on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a report on Tuesday, December 17th. Citigroup lowered their target price on McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Bank of America cut their price target on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Evercore ISI increased their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $649.36.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.